Two Sigma Investments, LP Sc Pharmaceuticals Inc. Transaction History

Two Sigma Investments, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$4.7 - $6.63 $90,710 - $127,959	-19,300 Reduced 60.31%	12,700 $79,000
Q3 2023 Nov 14, 2023	SELL	$7.0 - $9.82 $133,000 - $186,580	-19,000 Reduced 37.25%	32,000 $227,000
Q2 2023 Aug 14, 2023	SELL	$8.94 - $11.74 $1.77 Million - $2.33 Million	-198,067 Reduced 79.52%	51,000 $519,000
Q1 2023 May 15, 2023	BUY	$5.59 - $9.47 $336,026 - $569,260	60,112 Added 31.81%	249,067 $2.26 Million
Q4 2022 Feb 14, 2023	BUY	$4.02 - $7.53 $759,599 - $1.42 Million	188,955 New	188,955 $1.35 Million
Q4 2020 Feb 16, 2021	SELL	$5.17 - $9.41 $136,327 - $248,132	-26,369 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$7.12 - $8.86 $187,747 - $233,629	26,369 New	26,369 $196,000

37.1M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $90.2M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.